Technical Analysis for DGX - Quest Diagnostics Incorporated

Grade Last Price % Change Price Change
F 114.79 0.14% 0.16
DGX closed down 0.96 percent on Thursday, February 25, 2021, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical DGX trend table...

Date Alert Name Type % Chg
Oversold Stochastic Weakness 0.14%
Slingshot Bearish Bearish Swing Setup -0.82%
NR7 Range Contraction -0.82%
Oversold Stochastic Weakness -0.82%
Hammer Candlestick Bullish -2.30%
Stochastic Buy Signal Bullish -2.30%
Lower Bollinger Band Walk Weakness -2.30%
Lower Bollinger Band Touch Weakness -2.30%
Oversold Stochastic Weakness -2.30%
Below Lower BB Weakness -1.22%
Older End-of-Day Signals for DGX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Quest Diagnostics Incorporated Description

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business offers clinical testing services, including routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights. The Diagnostic Solutions business provides risk assessment services for the life insurance industry; clinical testing services for new drugs, vaccines, and medical devices; and clinical connectivity and data management solutions for healthcare organizations and clinicians to improve patient care and medical practice, as well as develops, manufactures, and markets diagnostics products. Its products include HemoCue, a point-of-care testing product for hemoglobin, glucose, microalbumin, and white blood cell testing; Care360 HER that allows doctors to electronically create, manage, and distribute patient encounter notes; and ChartMaxx, an electronic document management system for hospitals. The company offers its services to patients, physicians, hospitals, integrated delivery networks, health plans, employers, governmental institutions, and other commercial clinical laboratories through a network of laboratories and patient service centers. Quest Diagnostics Incorporated has a strategic alliance with Hologic, Inc. to offer testing based on Hologic's APTIMA family of products, as well as to co-develop and promote advanced diagnostic solutions to improve women's health. The company was founded in 1967 and is headquartered in Madison, New Jersey.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Insurance Industry Lab Testing Glucose Document Management Healthcare Organizations Hemoglobin Risk Assessment Anatomical Pathology Pathology Data Management Solution Data Management Solutions Radiometer Diagnostics Products Diagnostic Solutions Maxx Medical Diagnosis Corning Inc. Document Management System Pathology Services Quest Diagnostics Sunquest Information Systems

Is DGX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 134.71
52 Week Low 73.02
Average Volume 1,250,442
200-Day Moving Average 119.43
50-Day Moving Average 122.83
20-Day Moving Average 122.75
10-Day Moving Average 120.02
Average True Range 3.47
ADX 19.27
+DI 14.50
-DI 30.54
Chandelier Exit (Long, 3 ATRs ) 124.29
Chandelier Exit (Short, 3 ATRs ) 123.78
Upper Bollinger Band 132.34
Lower Bollinger Band 113.16
Percent B (%b) 0.08
BandWidth 15.62
MACD Line -2.16
MACD Signal Line -1.10
MACD Histogram -1.0662
Fundamentals Value
Market Cap 15.45 Billion
Num Shares 135 Million
EPS 8.11
Price-to-Earnings (P/E) Ratio 14.13
Price-to-Sales 2.03
Price-to-Book 2.63
PEG Ratio 1.56
Dividend 2.24
Dividend Yield 1.95%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 119.28
Resistance 3 (R3) 119.50 118.17 118.51
Resistance 2 (R2) 118.17 116.99 118.06 118.25
Resistance 1 (R1) 116.40 116.25 115.74 116.18 117.99
Pivot Point 115.07 115.07 114.74 114.96 115.07
Support 1 (S1) 113.30 113.89 112.64 113.08 111.27
Support 2 (S2) 111.97 113.15 111.86 111.01
Support 3 (S3) 110.20 111.97 110.76
Support 4 (S4) 109.98